atural daylight to improve 24h metabolism and glucose control in type 2 diabetes individuals - Natural office light and diabetes

niversity of Maastricht0 个研究点目标入组 18 人开始时间: 待定最近更新: 2024年4月15日

试验速览

暂无简介。

•Insulin treatment
•Uncontrolled hypertension
•Signs of active diabetes-related co-morbidities like active cardiovascular
•diseases, active diabetic foot, polyneuropathy or retinopathy
•Signs of active liver or kidney malfunction
•Use of SGLT2 inhibitors
•Using > 400mg caffeine daily (more than 4 coffee or energy drink)
•Extreme early bird or extreme night person (score <=30 or >=70 on MEQ-SA
•questionnaire)
•shift work or travel across more than one time zone in the 3 months before
•Heavily varying sleep-wake rhythm
•engagement in programmed exercise for more than 3h/week
•Any medication that will interfere with the study outcomes or hamper the
•safety of the participant
•Alcohol consumption of >2 servings per day for man and >1 serving per day for
•Subjects who do not want to be informed about unexpected medical findings
•during the screening /study, or do not wish that their physician is informed, 1
•month prior to the screening visit
•Significant food allergies/intolerance (seriously hampering study meals)
•Participation in another biomedical study within 1 month before the first
•study visit
•Smoking in the past 6 months
•A medical doctor will judge participation eligibility based on the medical
•history questionnaire, medication use and fasting blood parameters. If the
•medical doctor advises that a patient cannot participate, the patient will be
•excluded from enrollment.

发起方

niversity of Maastricht